Ignite Creation Date:
2025-12-25 @ 12:43 AM
Ignite Modification Date:
2026-02-01 @ 4:19 PM
Study NCT ID:
NCT00688467
Status:
COMPLETED
Last Update Posted:
2019-01-02
First Post:
2008-05-29
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Efficacy and Safety of Navarixin (SCH 527123) in Participants With Allergen-Induced Asthma (P05363)
Sponsor:
Merck Sharp & Dohme LLC
Organization: